ReP USP - Resultado da busca

Trabalho de evento-resumo
Novel HMG-CoA reductase inhibitors development by integrating dyslipidemic patients genetic studies and molecular modelling (2019)
Ferreira, Glaucio Monteiro ; Oliveira, Victor Fernandes de ; Kronenberger, Thales ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Feres, Fausto
Fonte: Proceedings. Nome do evento: International Conference of the Brazilian Association of Bioinformatics and Computational Biology/AB3C. Unidade: FCF
Assuntos: MODELAGEM MOLECULAR, DISLIPIDEMIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Glaucio Monteiro et al. Novel HMG-CoA reductase inhibitors development by integrating dyslipidemic patients genetic studies and molecular modelling. 2019, Anais.. Campos do Jordão: Associação Brasileira de Bioinformática e Biologia Computacional/AB3C, 2019. . Acesso em: 02 ago. 2024.
APA
Ferreira, G. M., Oliveira, V. F. de, Kronenberger, T., Hirata, R. D. C., Hirata, M. H., & Feres, F. (2019). Novel HMG-CoA reductase inhibitors development by integrating dyslipidemic patients genetic studies and molecular modelling. In Proceedings. Campos do Jordão: Associação Brasileira de Bioinformática e Biologia Computacional/AB3C.
NLM
Ferreira GM, Oliveira VF de, Kronenberger T, Hirata RDC, Hirata MH, Feres F. Novel HMG-CoA reductase inhibitors development by integrating dyslipidemic patients genetic studies and molecular modelling. Proceedings. 2019 ;[citado 2024 ago. 02 ]
Vancouver
Ferreira GM, Oliveira VF de, Kronenberger T, Hirata RDC, Hirata MH, Feres F. Novel HMG-CoA reductase inhibitors development by integrating dyslipidemic patients genetic studies and molecular modelling. Proceedings. 2019 ;[citado 2024 ago. 02 ]
Artigo de periodico
Advances with support vector machines for novel drug discovery (2019)
Maltarollo, Vinicius Gonçalves; Kronenberger, Thales; Espinoza, Gabriel Zarzana; Oliveira, Patricia Rufino; Honorio, Kathia Maria
Fonte: Expert Opinion on Drug Discovery. Unidade: EACH
Assuntos: QUÍMICA MÉDICA, PLANEJAMENTO DE FÁRMACOS, RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTAROLLO, Vinicius Gonçalves et al. Advances with support vector machines for novel drug discovery. Expert Opinion on Drug Discovery, v. 14, n. Ja 2019, p. 01-11, 2019Tradução . . Disponível em: https://doi.org/10.1080/17460441.2019.1549033. Acesso em: 02 ago. 2024.
APA
Maltarollo, V. G., Kronenberger, T., Espinoza, G. Z., Oliveira, P. R., & Honorio, K. M. (2019). Advances with support vector machines for novel drug discovery. Expert Opinion on Drug Discovery, 14( Ja 2019), 01-11. doi:10.1080/17460441.2019.1549033
NLM
Maltarollo VG, Kronenberger T, Espinoza GZ, Oliveira PR, Honorio KM. Advances with support vector machines for novel drug discovery [Internet]. Expert Opinion on Drug Discovery. 2019 ; 14( Ja 2019): 01-11.[citado 2024 ago. 02 ] Available from: https://doi.org/10.1080/17460441.2019.1549033
Vancouver
Maltarollo VG, Kronenberger T, Espinoza GZ, Oliveira PR, Honorio KM. Advances with support vector machines for novel drug discovery [Internet]. Expert Opinion on Drug Discovery. 2019 ; 14( Ja 2019): 01-11.[citado 2024 ago. 02 ] Available from: https://doi.org/10.1080/17460441.2019.1549033
Artigo de periodico
Advances and challenges in drug design of PPARδ ligands (2018)
Maltarollo, Vinícius Gonçalves ; Kronenberger, Thales ; Windshuegel, Bjoern ; Wrenger, Carsten ; Trossini, Gustavo Henrique Goulart ; Honório, Káthia Maria
Fonte: Current Drug Targets. Unidades: ICB, FCF, EACH
Assuntos: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, SÍNDROME X METABÓLICA, ÁCIDOS GRAXOS, DOENÇAS METABÓLICAS, PARASITOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTAROLLO, Vinícius Gonçalves et al. Advances and challenges in drug design of PPARδ ligands. Current Drug Targets, v. 19, n. 2, p. 144-154, 2018Tradução . . Disponível em: https://doi.org/10.2174/1389450118666170414113159. Acesso em: 02 ago. 2024.
APA
Maltarollo, V. G., Kronenberger, T., Windshuegel, B., Wrenger, C., Trossini, G. H. G., & Honório, K. M. (2018). Advances and challenges in drug design of PPARδ ligands. Current Drug Targets, 19( 2), 144-154. doi:10.2174/1389450118666170414113159
NLM
Maltarollo VG, Kronenberger T, Windshuegel B, Wrenger C, Trossini GHG, Honório KM. Advances and challenges in drug design of PPARδ ligands [Internet]. Current Drug Targets. 2018 ; 19( 2): 144-154.[citado 2024 ago. 02 ] Available from: https://doi.org/10.2174/1389450118666170414113159
Vancouver
Maltarollo VG, Kronenberger T, Windshuegel B, Wrenger C, Trossini GHG, Honório KM. Advances and challenges in drug design of PPARδ ligands [Internet]. Current Drug Targets. 2018 ; 19( 2): 144-154.[citado 2024 ago. 02 ] Available from: https://doi.org/10.2174/1389450118666170414113159
Artigo de periodico
Current trends in quantitative structure-activity relationship validation and applications on drug discovery (2017)
Maltarollo, Vinicius G.; Kronenberger, Thales; Wrenger, Carsten ; Honorio, Káthia Maria
Fonte: Future Science OA. Unidades: EACH, ICB
Assuntos: RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA, PLANEJAMENTO DE FÁRMACOS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTAROLLO, Vinicius G. et al. Current trends in quantitative structure-activity relationship validation and applications on drug discovery. Future Science OA, v. 3, n. 4, p. FSO214-FSO216, 2017Tradução . . Disponível em: https://doi.org/10.4155/fsoa-2017-0052. Acesso em: 02 ago. 2024.
APA
Maltarollo, V. G., Kronenberger, T., Wrenger, C., & Honorio, K. M. (2017). Current trends in quantitative structure-activity relationship validation and applications on drug discovery. Future Science OA, 3( 4), FSO214-FSO216. doi:10.4155/fsoa-2017-0052
NLM
Maltarollo VG, Kronenberger T, Wrenger C, Honorio KM. Current trends in quantitative structure-activity relationship validation and applications on drug discovery [Internet]. Future Science OA. 2017 ; 3( 4): FSO214-FSO216.[citado 2024 ago. 02 ] Available from: https://doi.org/10.4155/fsoa-2017-0052
Vancouver
Maltarollo VG, Kronenberger T, Wrenger C, Honorio KM. Current trends in quantitative structure-activity relationship validation and applications on drug discovery [Internet]. Future Science OA. 2017 ; 3( 4): FSO214-FSO216.[citado 2024 ago. 02 ] Available from: https://doi.org/10.4155/fsoa-2017-0052
Artigo de periodico
Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses (2017)
Kronenberger, Thales; Asse Junior, Leonardo Rander; Wrenger, Carsten ; Trossini, Gustavo Henrique Goulart ; Honorio, Kathia Maria; Maltarollo, Vinícius Gonçalves
Fonte: Future Medicinal Chemistry. Unidades: EACH, ICB, FCF
Assuntos: STAPHYLOCOCCUS, RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA, MODELAGEM MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KRONENBERGER, Thales et al. Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses. Future Medicinal Chemistry, v. 9, n. 2, p. 135-151, 2017Tradução . . Disponível em: https://doi.org/10.4155/fmc-2016-0179. Acesso em: 02 ago. 2024.
APA
Kronenberger, T., Asse Junior, L. R., Wrenger, C., Trossini, G. H. G., Honorio, K. M., & Maltarollo, V. G. (2017). Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses. Future Medicinal Chemistry, 9( 2), 135-151. doi:10.4155/fmc-2016-0179
NLM
Kronenberger T, Asse Junior LR, Wrenger C, Trossini GHG, Honorio KM, Maltarollo VG. Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses [Internet]. Future Medicinal Chemistry. 2017 ; 9( 2): 135-151.[citado 2024 ago. 02 ] Available from: https://doi.org/10.4155/fmc-2016-0179
Vancouver
Kronenberger T, Asse Junior LR, Wrenger C, Trossini GHG, Honorio KM, Maltarollo VG. Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses [Internet]. Future Medicinal Chemistry. 2017 ; 9( 2): 135-151.[citado 2024 ago. 02 ] Available from: https://doi.org/10.4155/fmc-2016-0179
Artigo de periodico
Oxidative stress control by apicomplexan parasites (2015)
Bosch, Soraya Soledad; Kronenberger, Thales; Meissner, Kamila Anna; Zimbres, Flávia Menezes; Stegehake, Dirk; Izui, Natália M.; Schettert, Isolmar; Liebau, Eva; Wrenger, Carsten
Fonte: BioMed Research International. Unidade: ICB
Assuntos: PARASITOLOGIA, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOSCH, Soraya Soledad et al. Oxidative stress control by apicomplexan parasites. BioMed Research International, v. 2015, p. 1-10, 2015Tradução . . Disponível em: https://doi.org/10.1155/2015/351289. Acesso em: 02 ago. 2024.
APA
Bosch, S. S., Kronenberger, T., Meissner, K. A., Zimbres, F. M., Stegehake, D., Izui, N. M., et al. (2015). Oxidative stress control by apicomplexan parasites. BioMed Research International, 2015, 1-10. doi:10.1155/2015/351289
NLM
Bosch SS, Kronenberger T, Meissner KA, Zimbres FM, Stegehake D, Izui NM, Schettert I, Liebau E, Wrenger C. Oxidative stress control by apicomplexan parasites [Internet]. BioMed Research International. 2015 ; 2015 1-10.[citado 2024 ago. 02 ] Available from: https://doi.org/10.1155/2015/351289
Vancouver
Bosch SS, Kronenberger T, Meissner KA, Zimbres FM, Stegehake D, Izui NM, Schettert I, Liebau E, Wrenger C. Oxidative stress control by apicomplexan parasites [Internet]. BioMed Research International. 2015 ; 2015 1-10.[citado 2024 ago. 02 ] Available from: https://doi.org/10.1155/2015/351289
Artigo de periodico
Purification, crystallization and preliminary X-ray diffraction analysis of pyridoxal kinase from Plasmodium falciparum (PfPdxK) (2014)
Kronenberger, Thales; Lunev, Sergey; Wrenger, Carsten ; Groves, Matthew R.
Fonte: Acta Crystallographica Section F, Structural Biology Communications. Unidade: ICB
Assuntos: PARASITOLOGIA, PLASMODIUM FALCIPARUM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KRONENBERGER, Thales et al. Purification, crystallization and preliminary X-ray diffraction analysis of pyridoxal kinase from Plasmodium falciparum (PfPdxK). Acta Crystallographica Section F, Structural Biology Communications, v. 70, p. 1550-1555, 2014Tradução . . Disponível em: https://doi.org/10.1107/S2053230X14019864. Acesso em: 02 ago. 2024.
APA
Kronenberger, T., Lunev, S., Wrenger, C., & Groves, M. R. (2014). Purification, crystallization and preliminary X-ray diffraction analysis of pyridoxal kinase from Plasmodium falciparum (PfPdxK). Acta Crystallographica Section F, Structural Biology Communications, 70, 1550-1555. doi:10.1107/S2053230X14019864
NLM
Kronenberger T, Lunev S, Wrenger C, Groves MR. Purification, crystallization and preliminary X-ray diffraction analysis of pyridoxal kinase from Plasmodium falciparum (PfPdxK) [Internet]. Acta Crystallographica Section F, Structural Biology Communications. 2014 ; 70 1550-1555.[citado 2024 ago. 02 ] Available from: https://doi.org/10.1107/S2053230X14019864
Vancouver
Kronenberger T, Lunev S, Wrenger C, Groves MR. Purification, crystallization and preliminary X-ray diffraction analysis of pyridoxal kinase from Plasmodium falciparum (PfPdxK) [Internet]. Acta Crystallographica Section F, Structural Biology Communications. 2014 ; 70 1550-1555.[citado 2024 ago. 02 ] Available from: https://doi.org/10.1107/S2053230X14019864
Artigo de periodico
Vitamin B6-dependent enzymes in the human malaria parasite Plasmodium falciparum: a druggable target? (2014)
Kronenberger, Thales; Lindner, Jasmin; Meissner, Kamila Anna; Zimbres, Flávia Menezes; Coronado, Monika A.; Sauer, Frank Martin; Schettert, Isolmar; Wrenger, Carsten
Fonte: Biomed Research International. Unidade: ICB
Assunto: PARASITOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KRONENBERGER, Thales et al. Vitamin B6-dependent enzymes in the human malaria parasite Plasmodium falciparum: a druggable target?. Biomed Research International, v. 2014, p. 1-11, 2014Tradução . . Disponível em: https://doi.org/10.1155/2014/108516. Acesso em: 02 ago. 2024.
APA
Kronenberger, T., Lindner, J., Meissner, K. A., Zimbres, F. M., Coronado, M. A., Sauer, F. M., et al. (2014). Vitamin B6-dependent enzymes in the human malaria parasite Plasmodium falciparum: a druggable target? Biomed Research International, 2014, 1-11. doi:10.1155/2014/108516
NLM
Kronenberger T, Lindner J, Meissner KA, Zimbres FM, Coronado MA, Sauer FM, Schettert I, Wrenger C. Vitamin B6-dependent enzymes in the human malaria parasite Plasmodium falciparum: a druggable target? [Internet]. Biomed Research International. 2014 ; 2014 1-11.[citado 2024 ago. 02 ] Available from: https://doi.org/10.1155/2014/108516
Vancouver
Kronenberger T, Lindner J, Meissner KA, Zimbres FM, Coronado MA, Sauer FM, Schettert I, Wrenger C. Vitamin B6-dependent enzymes in the human malaria parasite Plasmodium falciparum: a druggable target? [Internet]. Biomed Research International. 2014 ; 2014 1-11.[citado 2024 ago. 02 ] Available from: https://doi.org/10.1155/2014/108516
Artigo de periodico
Targeting the vitamin biosynthesis pathways for the treatment of malaria (2013)
Kronenberger, Thales; Schettert, Isolmar; Wrenger, Carsten
Fonte: Future Medicinal Chemistry. Unidade: ICB
Assunto: PARASITOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KRONENBERGER, Thales e SCHETTERT, Isolmar e WRENGER, Carsten. Targeting the vitamin biosynthesis pathways for the treatment of malaria. Future Medicinal Chemistry, v. 5, n. 7, p. 769-779, 2013Tradução . . Disponível em: https://doi.org/10.4155/FMC.13.43. Acesso em: 02 ago. 2024.
APA
Kronenberger, T., Schettert, I., & Wrenger, C. (2013). Targeting the vitamin biosynthesis pathways for the treatment of malaria. Future Medicinal Chemistry, 5( 7), 769-779. doi:10.4155/FMC.13.43
NLM
Kronenberger T, Schettert I, Wrenger C. Targeting the vitamin biosynthesis pathways for the treatment of malaria [Internet]. Future Medicinal Chemistry. 2013 ; 5( 7): 769-779.[citado 2024 ago. 02 ] Available from: https://doi.org/10.4155/FMC.13.43
Vancouver
Kronenberger T, Schettert I, Wrenger C. Targeting the vitamin biosynthesis pathways for the treatment of malaria [Internet]. Future Medicinal Chemistry. 2013 ; 5( 7): 769-779.[citado 2024 ago. 02 ] Available from: https://doi.org/10.4155/FMC.13.43

Unidades USP

ReP

Filtros

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Indexado em

Afiliação dos autores externos não normalizada